Carbapenem-resistant enterobacteriaceae producing OXA-48-like carbapenemases — United States, 2010–2015

Morbidity and Mortality Weekly Report

Volumn 64, Issue 47, 2015, Pages 1315-1316

  Lyman, Meghan M ^a,b   Walters, Maroya ^b   Lonsway, David ^b   Rasheed, Kamile ^b   Limbago, Brandi ^b   Kallen, Alexander ^b  

^a CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^b NATIONAL CENTER FOR EMERGING AND ZOONOTIC INFECTIOUS DISEASES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIAL PROTEIN; BETA LACTAMASE; CARBAPENEM DERIVATIVE; CARBAPENEMASE;

ADULT; AGED; ANTIBIOTIC RESISTANCE; BIOSYNTHESIS; CLUSTER ANALYSIS; DRUG EFFECTS; ENTEROBACTERIACEAE; ENTEROBACTERIACEAE INFECTIONS; HOSPITALIZATION; HUMAN; INTERNATIONAL COOPERATION; ISOLATION AND PURIFICATION; MIDDLE AGED; PUBLIC HEALTH SERVICE; TRAVEL; UNITED STATES; VERY ELDERLY;

ADULT; AGED; AGED, 80 AND OVER; BACTERIAL PROTEINS; BETA-LACTAMASES; CARBAPENEMS; CENTERS FOR DISEASE CONTROL AND PREVENTION (U.S.); CLUSTER ANALYSIS; DRUG RESISTANCE, BACTERIAL; ENTEROBACTERIACEAE; ENTEROBACTERIACEAE INFECTIONS; HOSPITALIZATION; HUMANS; INTERNATIONALITY; MIDDLE AGED; TRAVEL; UNITED STATES;

EID: 84951089587     PISSN: 01492195     EISSN: 1545861X     Source Type: Journal    
DOI: 10.15585/mmwr.mm6447a3     Document Type: Article

References (10)

1. Gupta N, Limbago BM, Patel JB, Kallen AJ. Carbapenem-resistant Enterobacteriaceae: epidemiology and prevention. Clin Infect Dis 2011;53:60-7.
2. Liu Y, Wang Y, Walsh TR, et al. Emergence of plasmid-mediated colistin resistance mechanism MCR-1 in animals and human beings in China: a microbiological and molecular biological study. Lancet. Epub Nov 18, 2015.
3. Humphries RM, Yang S, Hemarajata P, et al. First report of ceftazidime-avibactam resistance in a KPC-3-expressing Klebsiella pneumoniae isolate. Antimicrob Agents Chemother 2015;59:6605-7.
4. Poirel L, Potron A, Nordmann P. OXA-48-like carbapenemases: the phantom menace. J Antimicrob Chemother 2012;67:1597-606.
5. Lascols C, Peirano G, Hackel M, Laupland KB, Pitout JD. Surveillance and molecular epidemiology of Klebsiella pneumoniae isolates that produce carbapenemases: first report of OXA-48-like enzymes in North America. Antimicrob Agents Chemother 2013;57:130-6.
6. Mathers AJ, Hazen KC, Carroll J, et al. First clinical cases of OXA-48-producing carbapenem-resistant Klebsiella pneumoniae in the United States: the "menace" arrives in the new world. J Clin Microbiol 2013;51:680-3.
7. Doi Y, O'Hara JA, Lando JF, et al. Co-production of NDM-1 and OXA-232 by Klebsiella pneumoniae. Emerg Infect Dis 2014;20:163-5.
8. Nordmann P, Poirel L. The difficult-to-control spread of carbapenemase producers among Enterobacteriaceae worldwide. Clin Microbiol Infect 2014;20:821-30.
9. CDC. FAQs about choosing and implementing a CRE definition. CDC Healthcare-associated infections. Atlanta, GA: US Department of Health and Human Services, CDC. Available at http://www.cdc.gov/hai/ organisms/cre/definition.html.
10. CDC Health Alert Network. New carbapenem-resistant enterobacteriaceae warrant additional action by healthcare providers. Atlanta, GA: US Department of Health and Human Services, CDC; 2013. Available at http://emergency.cdc.gov/han/han00341.asp.